Ginkgo Bioworks

NYU Langone Health experts advise gradual, sustainable weight loss strategies and highlight alcohol's cancer risks, even at moderate levels. Studies show psilocybin's mental health benefits and zebrafish research offers insights into newborn gaze stabilization. The Mediterranean diet tops U.S. News & World Report's 2025 best diets. Respiratory illnesses surge in Washington, and a Costco cold remedy is recalled.

MAIA Biotechnology's CEO, Vlad Vitoc, M.D., will present at Biotech Showcase 2025, discussing THIO-101 Phase 2 trial expansion for NSCLC and upcoming THIO trials in various cancer indications. THIO, a telomere-targeting agent, aims to induce cancer cell death and activate immune responses, with potential as a third-line NSCLC treatment.

Researchers at Penn Engineering developed mvGPT, a tool combining gene editing, activation, and repression capabilities. Tested on human liver cells, it successfully addressed multiple genetic issues simultaneously, offering a simpler, more efficient approach to treating genetic diseases and studying DNA functions.

The global DNA sequencing market, valued at USD 14.95 billion in 2024, is projected to reach USD 106.20 billion by 2034, growing at a CAGR of 21.66%. Growth drivers include advancements in next-generation sequencing, personalized treatments, and reduced costs. Key segments include consumables, services, next-generation sequencing, oncology, and academic research, with North America leading the market.

US Surgeon General Dr. Vivek Murthy proposes cancer warning labels on alcoholic beverages, citing evidence linking alcohol to increased cancer risk. Current labels, unchanged since 1988, omit cancer risks. Alcohol is a leading preventable cause of cancer, with no safe consumption level. Despite low public awareness, updated labels aim to inform and potentially reduce consumption, facing industry opposition.

2024 marked a pivotal year for Google AI, with major updates like Circle to Search, Gemini 2.0 models, and AI-powered features across products. Key announcements included AI advancements in health, education, and sustainability, alongside significant partnerships and investments in AI infrastructure and skills development.

General Proximity, a biotech company, emerged from stealth with its OmniTAC platform for induced proximity medicines, raising $16M. Backed by notable investors and a team of top scientists, it aims to target undruggable proteins in diseases like cancer and neurodegeneration, leveraging biological proximity for drug discovery.

Argentina's Kheiron S.A. achieved a global first by using CRISPR-Cas9 to genetically edit five horses, enhancing traits like speed and endurance without creating GMOs. This breakthrough, leveraging Argentina's polo horse breeding expertise, marks a significant advancement in equine genetics and biotechnology, with potential impacts on sports, conservation, and animal health.

Dr. Vivek Murthy, U.S. Surgeon General, highlights alcohol as a leading preventable cause of cancer, linking it to increased risks of breast and gastrointestinal cancers. He emphasizes the need for public awareness and lifestyle changes to reduce alcohol consumption and its health risks, advocating for prevention before medical intervention.

U.S. Surgeon General Vivek Murthy highlights alcohol as a major preventable cancer cause, responsible for 100,000 cases and 20,000 deaths annually. Alcohol, classified as a Group One carcinogen, increases risks of several cancers. No safe alcohol consumption level exists for cancer risk. Murthy advocates for cancer warnings on alcoholic drinks.